CanSino Biologics (HKSE:06185) Days Payable : 174.81 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Days Payable?

CanSino Biologics's average Accounts Payable for the three months ended in Mar. 2024 was HK$96.2 Mil. CanSino Biologics's Cost of Goods Sold for the three months ended in Mar. 2024 was HK$50.2 Mil. Hence, CanSino Biologics's Days Payable for the three months ended in Mar. 2024 was 174.81.

The historical rank and industry rank for CanSino Biologics's Days Payable or its related term are showing as below:

HKSE:06185' s Days Payable Range Over the Past 10 Years
Min: 36.96 Med: 151.57 Max: 877.39
Current: 36.96

During the past 8 years, CanSino Biologics's highest Days Payable was 877.39. The lowest was 36.96. And the median was 151.57.

HKSE:06185's Days Payable is ranked worse than
85.33% of 975 companies
in the Drug Manufacturers industry
Industry Median: 87.13 vs HKSE:06185: 36.96

CanSino Biologics's Days Payable declined from Mar. 2023 (347.40) to Mar. 2024 (174.81). It may suggest that CanSino Biologics accelerated paying its suppliers.

CanSino Biologics Days Payable Historical Data

The historical data trend for CanSino Biologics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Days Payable Chart

CanSino Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

877.39

126.73

176.41

54.16

CanSino Biologics Quarterly Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial													347.40	23.43	-	10.08	174.81

Competitive Comparison of CanSino Biologics's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanSino Biologics's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's Days Payable distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's Days Payable falls into.

CanSino Biologics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

CanSino Biologics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (282.663	+	113.72)	/	2 )	/	1335.724	*	365
=	198.1915					/	1335.724	*	365
=	54.16

CanSino Biologics's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (113.72	+	78.7)	/	2 )	/	50.222	*	365 / 4
=	96.21					/	50.222	*	365 / 4
=	174.81

CanSino Biologics Days Payable Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

CanSino Biologics (HKSE:06185) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (HKSE:06185) » Definitions » Days Payable

Traded in Other Exchanges

CASBF:USA CJH:Germany 688185:China

Address

185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN

Website

https://www.cansinotech.com

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.

CanSino Biologics (HKSE:06185) Headlines

No Headlines